TP53 and hepatocellular carcinoma: In mouse models of liver cancer, p53 induces the expression of the ABCA1 cholesterol transporter gene via transcription, blocking the activation of SREBP‐2, the main transcriptional regulator of this pathway, thus inhibiting HCC development [98].